Skip to main content
Clinical Trials/JPRN-UMIN000012283
JPRN-UMIN000012283
Completed
未知

Clinical and immunological analysis on the effect of LEM in the adoptive immunotherapy using autologous activated lymphocytes in patients with incurable cancer - LEM on AIT for Cancer

Kawasaki Medical School0 sites20 target enrollmentDecember 1, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Incurable cancer
Sponsor
Kawasaki Medical School
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2013
End Date
August 17, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Autoimmune disease 2\) Uncontrollable complications including infection, diabetes, hypertension, ischemic heart disease, cerebral infarction, interstitial pneumonitis, cancer pain 3\) Pregnancy 4\) Allergy 5\) General symptoms including dyspnea, jaundice, edema, effusions, clamp, paralysis, fracture, difficult for out\-patient 6\) Steroid or immunosuppressive agents 7\) Other unacceptable reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials